Mint Tower Capital Management’s Pfizer PFE Stock Holding History

Mint Tower Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-48,900	Closed	-$1.92M	–	358
2021 Q2	$1.92M	Buy	48,900 +17,500	+56%	+$681K	0.14%	129
2021 Q1	$1.13M	Buy	+31,400	New	+$1.11M	0.11%	143
2020 Q3	–	Sell	-35,836	Closed	-$1.11M	–	301
2020 Q2	$1.11M	Buy	35,836 +8,959	+33%	+$304K	0.13%	109
2020 Q1	$824K	Buy	+26,877	New	+$916K	0.16%	116
2018 Q4	–	Sell	-105,400	Closed	-$4.41M	–	217
2018 Q3	$4.41M	Sell	105,400 -170,748	-62%	-$6.57M	0.55%	39
2018 Q2	$9.51M	Buy	+276,148	New	+$9.44M	1.27%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mint Tower Capital Management's PFE Position: Q4 2021 in Review

Mint Tower Capital Management sold out of Pfizer (PFE) in Q4 2021, closing a stake of 3,338 shares — an estimated $144K sold.

Mint Tower Capital Management first reported a position in PFE in Q2 2020 and held it in 2 quarters. The position peaked at $627K in Q2 2020. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Mint Tower Capital Management reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
Mint Tower Capital Management sold 3,338 Pfizer shares in Q4 2021, an estimated $144K.
Mint Tower Capital Management first reported a position in Pfizer in Q2 2020 and held it in 2 quarters.
Mint Tower Capital Management's Pfizer position peaked at $627K in Q2 2020.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Mint Tower Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.